A blood pressure medication distributed by a New Jersey company has been voluntarily recalled, according to the U.S Food and Drug Administration.
Chlorthalidone tablets — which are used to treat high blood pressure — made by Inventia Healthcare Limited have been recalled after failing to meet dissolution specifications, which may cause them to work incorrectly.
Dissolution testing measures how well a drug releases into the body. If a medication fails this testing, it may not provide the prescribed dosage.
A total of 11,460 bottles of chlorthalidone tablets have been recalled nationwide.
All recalled tablets are 25 milligrams, in both 100-tablet bottles and 1,000-tablet bottles. Affected batches are RISA24001 and RISB24002.
Medicines that have been recalled have an expiration date of April 2027.
If you or a loved one has suffered losses due to ingesting this or any Inventia Healthcare Limited medication, you may be entitled to compensation. To learn more, contact Breslin and Breslin today.
